These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 52559)

  • 1. Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors.
    Crain SM; Bornstein MB
    Exp Neurol; 1975 Oct; 49(1 Pt 1):330-5. PubMed ID: 52559
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera.
    Bradbury K; Aparicio SR; Sumner DW; Bird CC
    J Neurol Sci; 1984 Sep; 65(3):293-305. PubMed ID: 6491691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: an immunologic reassessment.
    Paterson PY
    J Chronic Dis; 1973 Mar; 26(3):119-26. PubMed ID: 4348606
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production of gamma globulins in the central nervous system during experimental allergic encephalomyelitis].
    Pozzuoli R; Musiani P
    Riv Patol Nerv Ment; 1969 Jun; 90(3):197-211. PubMed ID: 4107146
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue culture studies of neuroelectric blocking factors.
    Seil FJ
    Adv Neurol; 1981; 31():281-8. PubMed ID: 7325045
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of encephalitogenic basic protein by serum alpha-globulins.
    McPherson TA; Marchalonis JJ; Lennon V
    Immunology; 1970 Dec; 19(6):929-33. PubMed ID: 4098879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 8. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyamics of the clinico-immunologic and histopathologic changes in the development of experimental allergic encephalomyelitis].
    Savenko SN; Tauber IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):171-5. PubMed ID: 4173467
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models for multiple sclerosis.
    Owens T
    Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on autoimmune encephalomyelitis in the guinea pig--III. A comparative study of two autoantigens of central nervous system myelin.
    Lebar R; Vincent C; Fischer-le Boubennec E
    J Neurochem; 1979 May; 32(5):1451-60. PubMed ID: 438816
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the complement system in the pathogenesis of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Terényi N; Prechl J; Erdei A
    Adv Exp Med Biol; 2006; 586():177-88. PubMed ID: 16893072
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological approach to neurological diseases].
    Igata A; Beppu H
    Shinkei Kenkyu No Shimpo; 1969 Nov; 13(3):519-33. PubMed ID: 4190030
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.
    Bornstein MB; Iwanami H
    J Neuropathol Exp Neurol; 1971 Apr; 30(2):240-8. PubMed ID: 5147780
    [No Abstract]   [Full Text] [Related]  

  • 17. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological studies in experimental allergic encephalomyelitis and in multiple sclerosis with special reference to pathogenesis and diagnosis.
    Lamoureux G
    Proc Aust Assoc Neurol; 1966; 4():125-32. PubMed ID: 4165114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].
    Halpern B; Bakouche P; Martial-Lasfargues C
    Presse Med (1893); 1969 Dec; 77(55):2103-6. PubMed ID: 4190510
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroglia and the myelin-bearing cell: a symposium. Immunological factors in experimental allergic encephalomyelitis and multiple sclerosis as revealed by cultures of mammalian nerve tissue.
    Bornstein MB
    J Neurol Neurosurg Psychiatry; 1969 Apr; 32(2):163-4. PubMed ID: 4306415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.